Log in to save to my catalogue

Methotrexate treatment for peritoneal trophoblastic implants after laparoscopic salpingectomy and se...

Methotrexate treatment for peritoneal trophoblastic implants after laparoscopic salpingectomy and se...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2919746572

Methotrexate treatment for peritoneal trophoblastic implants after laparoscopic salpingectomy and secondary laparoscopic excision of ectopic pregnancy

About this item

Full title

Methotrexate treatment for peritoneal trophoblastic implants after laparoscopic salpingectomy and secondary laparoscopic excision of ectopic pregnancy

Publisher

England: BMJ Publishing Group Ltd

Journal title

BMJ case reports, 2024-01, Vol.17 (1), p.e257693

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

Ectopic pregnancy is a one of the primary causes of maternal mortality in first trimester. The most common site of ectopic pregnancy is the fallopian tube. Surgical management of tubal ectopic pregnancy includes salpingotomy or salpingectomy. Persistent ectopic pregnancy can happen after salpingotomy due to incomplete removal of ectopic tissue. How...

Alternative Titles

Full title

Methotrexate treatment for peritoneal trophoblastic implants after laparoscopic salpingectomy and secondary laparoscopic excision of ectopic pregnancy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2919746572

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2919746572

Other Identifiers

ISSN

1757-790X

E-ISSN

1757-790X

DOI

10.1136/bcr-2023-257693

How to access this item